Hmox2 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
HMOX2 (Heme Oxygenase 2) encodes the inducible form of heme oxygenase, an enzyme that catalyzes the breakdown of heme into biliverdin, iron, and carbon monoxide. HMOX2 is expressed in the brain and plays important roles in iron metabolism, oxidative stress response, and neuroprotection. Dysregulation of heme oxygenase activity has been implicated in Parkinson's disease, Alzheimer's disease, and other neurodegenerative disorders.
| Heme Oxygenase 2 | |
|---|---|
| Gene Symbol | HMOX2 |
| Full Name | Heme Oxygenase 2 |
| Chromosome | 16p13.3 |
| NCBI Gene ID | 3163 |
| OMIM | 141750 |
| Ensembl ID | ENSG00000103415 |
| UniProt ID | P30519 |
| Associated Diseases | Alzheimer's Disease, Parkinson's Disease, Neuroinflammation |
HMOX2 encodes heme oxygenase 2, an enzyme that catalyzes the degradation of heme into biliverdin, iron, and carbon monoxide (CO). Unlike HMOX1 (inducible), HMOX2 is constitutively expressed and provides baseline protection against heme-mediated oxidative damage. HMOX2 is highly expressed in the brain, particularly in neurons, where it plays important roles in neuroprotection, iron homeostasis, and anti-inflammatory signaling.
Constitutively expressed in brain, with high levels in neurons, astrocytes, and microglia. Unlike HMOX1, it is not strongly induced by stress.
| Disease | Role | Mechanism |
|---|---|---|
| Alzheimer's Disease | Protective | HMOX2 activity reduces heme toxicity and oxidative stress; decreased expression associated with disease progression |
| Parkinson's Disease | Protective | Protects dopaminergic neurons from oxidative damage; CO signaling has anti-apoptotic effects |
| Multiple Sclerosis | Protective | Modulates neuroinflammation and demyelination |
The study of Hmox2 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.